Pathology

Applications of Multiplex Immunofluorescence for Immune Biomarkers in Drug Development

Characterizing Tissue Biology with Next-Generation Image Analysis Workflows

The Digital Biomarker Revolution: How Large-Scale, Clinical-Grade AI Enables Novel CDXs from Histopathology

Uncovering New Biological Insights Using Advanced Pathology Image Analysis Tools

Optimization of a Novel Tissue Test to Visualize and Quantify Membrane PSMA Expression in Prostate Cancer

Next Generation Tissue Biomarker Assays to Advance Clinical Drug Development Applications

Imaging Biomarkers in Metastatic Prostate Cancer

Tissue-based Biomarker Imaging Applications for Oncology Drug Discovery and Development

In Vivo and Tissue Molecular Imaging in Gene Therapy

Novel Quantitative Immunohistochemistry Technology and Associated Applications

Clinical

The Evolution of RANO Criteria: Improving Accuracy in Brain Tumor Assessment

Molecular Imaging in Breast Cancer Drug Development: The Next Leap Forward

Molecular Imaging Agents in Development for IO Treatment Response

The Use of Radiation Dosimetry to Optimize Radiopharmaceutical Therapy

Multi-purpose in vivo Imaging in Intracranial Tumor Models to Support Clinical Translation in Neuro-oncology

Imaging Lessons from the VISION Trial

PET Immune Imaging in Drug Development, from Bench to Bedside Application, with Decision Making Capabilities

Understanding the Intricacies of Fluorine-18 and Carbon-11 for Radiolabeling Success

iPACS® and VivoQuant™ 2021 Enhancements

Advanced Metrics and Modeling with Volumetric CT for Precision Analysis of Clinical Trial Results

Quantitative Diagnostics in Anatomic Pathology

Characterizing Tissue Biology with Next-Generation Image Analysis Workflows

The Resurgence of Theranostics: Challenges and Successes of Clinical Application

The Evolution of Lymphoma-Based Oncology Response Criteria

EXPLORER as a Transformational Imaging Technology for Drug Development

Translating Radiolabeled Biologics – Strategies for Successful IND Submission

Segmentation of Lesions in Whole-Body PET/CT Using Deep Learning

Utilizing Imaging Agent Biomarkers for Improved Patient Management – Challenges and Successes

Panel Discussion - PSMA: Imaging Biomarker Development

Obtaining High Quality Imaging Data from Clinical Trials

The Changing Landscape of Response Assessment in Oncology

Next Generation Tissue Biomarker Assays to Advance Clinical Drug Development Applications

Optimization of a Novel Tissue Test to Visualize and Quantify Membrane PSMA Expression in Prostate Cancer

Uncovering New Biological Insights Using Advanced Pathology Image Analysis Tools

The Digital Biomarker Revolution: How Large-Scale, Clinical-Grade AI Enables Novel CDXs from Histopathology

What’s New in iPACS and VivoQuant With an Eye on the Future

Image Acquisition is Easy; Constructing Data Analysis Workflows that Work for you is the Challenging and Critical Part

Chemistry External Manufacturing and Network Management

Applications of Machine Learning in Medical Image Analysis

Imaging Biomarkers in Metastatic Prostate Cancer

Imaging in Immuno-Oncology

Machine Learning & Deep Learning for Image Processing Applications

How MRI is Helping to De-risk Drug Development

In Vivo and Tissue Molecular Imaging in Gene Therapy

Molecular Imaging and Alpha-Radiopharmaceutical Therapy

Preclinical

A novel 3D approach to imaging gene therapy expression and vector biodistribution

Molecular Imaging Agents in Development for IO Treatment Response

The Use of Radiation Dosimetry to Optimize Radiopharmaceutical Therapy

Multi-purpose in vivo Imaging in Intracranial Tumor Models to Support Clinical Translation in Neuro-oncology

PET Immune Imaging in Drug Development, from Bench to Bedside Application, with Decision Making Capabilities

Understanding the Intricacies of Fluorine-18 and Carbon-11 for Radiolabeling Success

iPACS® and VivoQuant™ 2021 Enhancements

Quantitative Diagnostics in Anatomic Pathology

Characterizing Tissue Biology with Next-Generation Image Analysis Workflows

The Resurgence of Theranostics: Challenges and Successes of Clinical Application

Next Generation Tissue Biomarker Assays to Advance Clinical Drug Development Applications

Optimization of a Novel Tissue Test to Visualize and Quantify Membrane PSMA Expression in Prostate Cancer

Uncovering New Biological Insights Using Advanced Pathology Image Analysis Tools

The Digital Biomarker Revolution: How Large-Scale, Clinical-Grade AI Enables Novel CDXs from Histopathology

Utilization of 3D Fluorescent Imaging in Multi-modality Studies

What’s New in iPACS and VivoQuant With an Eye on the Future

Applications of Machine Learning in Medical Image Analysis

Imaging Biomarkers in Metastatic Prostate Cancer

Rapid in vivo Screening of Gene Delivery, Anticancer Efficacy and Cell Trafficking Using Bioluminescence Imaging

Tissue-based Biomarker Imaging Applications for Oncology Drug Discovery and Development

Machine Learning & Deep Learning for Image Processing Applications

How MRI is Helping to De-risk Drug Development

In Vivo and Tissue Molecular Imaging in Gene Therapy

Molecular Imaging and Alpha-Radiopharmaceutical Therapy

Novel Quantitative Immunohistochemistry Technology and Associated Applications

Image Acquisition is Easy; Constructing Data Analysis Workflows that Work for you is the Challenging and Critical Part